2-Hydroxy-1-methoxyxanthoneCAS# 16302-46-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 16302-46-8 | SDF | Download SDF |
| PubChem ID | 10399460 | Appearance | Yellow powder |
| Formula | C14H10O4 | M.Wt | 242.23 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Synonyms | 2-Hydroxy-1-methoxy-xanthen-9-one | ||
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2-hydroxy-1-methoxyxanthen-9-one | ||
| SMILES | COC1=C(C=CC2=C1C(=O)C3=CC=CC=C3O2)O | ||
| Standard InChIKey | ATPZBKJDXXSOFC-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C14H10O4/c1-17-14-9(15)6-7-11-12(14)13(16)8-4-2-3-5-10(8)18-11/h2-7,15H,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
2-Hydroxy-1-methoxyxanthone Dilution Calculator
2-Hydroxy-1-methoxyxanthone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.1283 mL | 20.6415 mL | 41.2831 mL | 82.5662 mL | 103.2077 mL |
| 5 mM | 0.8257 mL | 4.1283 mL | 8.2566 mL | 16.5132 mL | 20.6415 mL |
| 10 mM | 0.4128 mL | 2.0642 mL | 4.1283 mL | 8.2566 mL | 10.3208 mL |
| 50 mM | 0.0826 mL | 0.4128 mL | 0.8257 mL | 1.6513 mL | 2.0642 mL |
| 100 mM | 0.0413 mL | 0.2064 mL | 0.4128 mL | 0.8257 mL | 1.0321 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Anhydroscandenolide
Catalog No.:BCN9698
CAS No.:114742-71-1
- Futoamide
Catalog No.:BCN9697
CAS No.:23477-80-7
- 14-O-Acetylneoline
Catalog No.:BCN9696
CAS No.:1354-86-5
- 1,5-Dihydroxy-6,7-dimethoxyxanthone
Catalog No.:BCN9695
CAS No.:38710-31-5
- Hancinone
Catalog No.:BCN9694
CAS No.:104013-61-8
- Icariside E4
Catalog No.:BCN9693
CAS No.:126253-42-7
- Murrayamine O
Catalog No.:BCN9692
CAS No.:166990-10-9
- Methyl lucidenate L
Catalog No.:BCN9691
CAS No.:110267-46-4
- 1,1'-bislusianthridin
Catalog No.:BCN9690
CAS No.:182296-65-7
- Jasamplexoside A
Catalog No.:BCN9689
CAS No.:147764-93-0
- Triandrin
Catalog No.:BCN9688
CAS No.:19764-35-3
- Jasamplexoside C
Catalog No.:BCN9687
CAS No.:147742-02-7
- 14-Benzoyl-8-O-methylaconine
Catalog No.:BCN9700
CAS No.:93772-68-0
- Adenostemmoic acid E
Catalog No.:BCN9701
CAS No.:130217-22-0
- Gancaonin J
Catalog No.:BCN9702
CAS No.:129280-37-1
- Indole-3-carboxylic acid β-D-glucopyranosyl ester
Catalog No.:BCN9703
CAS No.:106871-55-0
- Adenostemmoic acid G
Catalog No.:BCN9704
CAS No.:130217-26-4
- 12-O-Methylinophyllum D
Catalog No.:BCN9705
CAS No.:40883-10-1
- Onjixanthone I
Catalog No.:BCN9706
CAS No.:136083-92-6
- Adenostemmoside A
Catalog No.:BCN9707
CAS No.:130217-15-1
- Alaternin
Catalog No.:BCN9708
CAS No.:641-90-7
- Liquiridiolic acid
Catalog No.:BCN9709
CAS No.:20528-70-5
- Inophyllum E
Catalog No.:BCN9710
CAS No.:17312-31-1
- Isooxoflaccidin
Catalog No.:BCN9711
CAS No.:135010-50-3
Antistaphylococcal Prenylated Acylphoroglucinol and Xanthones from Kielmeyera variabilis.[Pubmed:26900954]
J Nat Prod. 2016 Mar 25;79(3):470-6.
Bioactivity-guided fractionation of the EtOH extract of the branches of Kielmeyera variabilis led to the isolation of a new acylphoroglucinol (1), which was active against all the MRSA strains tested herein, with pronounced activity against strain EMRSA-16. Compound 1 displayed an MIC of 0.5 mg/L as compared with an MIC of 128 mg/L for the control antibiotic norfloxacin. The structure of the new compound was elucidated by 1D and 2D NMR spectroscopic analysis and mass spectrometry, and experimental and calculated ECD were used to determine the absolute configurations. The compounds beta-sitosterol (2), stigmasterol (3), ergost-5-en-3-ol (4), and osajaxanthone (5) also occurred in the n-hexane fraction. The EtOAc fraction contained nine known xanthones: 3,6-dihydroxy-1,4,8-trimethoxyxanthone (6), 3,5-dihydroxy-4-methoxyxanthone (7), 3,4-dihydroxy-6,8-dimethoxyxanthone (8), 3,4-dihydroxy-2-methoxyxanthone (9), 5-hydroxy-1,3-dimethoxyxanthone (10), 4-hydroxy-2,3-dimethoxyxanthone (11), kielcorin (12), 3-hydroxy-2-methoxyxanthone (13), and 2-Hydroxy-1-methoxyxanthone (14), which showed moderate to low activity against the tested MRSA strains.
Assessment of anxiolytic and panicolytic effects of dichloromethane fraction from stems of Kielmeyera coriacea.[Pubmed:21975171]
Phytomedicine. 2012 Feb 15;19(3-4):374-7.
Kielmeyera coriacea Mart. (Calophyllaceae) is known popularly as "Pau Santo". The hydroethanolic extract (HE) of Kielmeyera coriacea stems and its semi-pure dichloromethane (DCM) constituent produced an antidepressant-like effect in rats. The purpose of this study was to investigate the effects of repeated administration (21 days) by gavage of the DCM fraction (5, 10 or 15mg/kg) in rats submitted to the elevated T-maze (ETM), a model of generalized anxiety and panic disorders. The tricyclic antidepressant imipramine (15mg/kg) was used as a positive control. Rat locomotion was assessed using the open field test (OFT) following each drug treatment. The 2-Hydroxy-1-methoxyxanthone (1), aucuparin (2), swertinin (3), 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (4) and 1,3,5-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (5) were identified in DCM fraction, and suggest that the xanthone (4) is related with the antidepressant-like profile of this plant. Pharmacological evaluation showed that DCM fraction (10 and 15 mg/kg) decreased the inhibitory avoidance latency from the closed arm and increased the one-way escape latency from the open arm in the ETM, which is indicative of anxiolytic and panicolytic effects, respectively, as occurs with the positive control, imipramine (15 mg/kg), when compared to their control group (vehicle). Locomotor activity was not significantly altered by the different treatments. This study suggests that the DCM fraction from stems of Kielmeyera coriacea can be an important therapeutic alternative in the treatment of anxiety disorders, such as generalized anxiety and panic disorders.
